What Did You Miss at the 3rd Spatial Biology for Drug Development Summit?

Spatial biology is at a turning point. Rapid advances in resolution, sensitivity, and multi-omics integration are delivering more robust and clinically meaningful insights than ever before. Recent collaborations and investments, such as GSK’s partnership with Relation Therapeutics and Sanofi’s expanded partnership with Owkin, highlight the strong momentum and confidence building across the sector. Yet, challenges around data standardization, integration, scalability, and cost continue to limit widespread adoption, particularly among small and mid-sized biopharma companies.

The 3rd Spatial Biology for Drug Development Summit was your opportunity to come together with industry experts to address these barriers head-on. The 2025 meeting connected leading biopharma, technology providers, and thought leaders to share practical examples, proven strategies, and clear value stories that demonstrate how spatial biology can deliver return on investment across discovery, translational research, and clinical development.

6 (1)

2025 Event Highlights

Tackle

reproducibility and standardization barriers to advance and scale spatial biology from early discovery to real-world impact — accelerating robust, industry-wide adoption

Discover

unprecedented insights into the tumor microenvironment with spatial transcriptomics to reveal novel biomarkers and fuel your therapeutic pipeline

Leverage

advanced computational pipelines to process complex spatial data at scale, delivering deeper insights into tissue architecture for novel breakthroughs

Enable

scalable, integrated data infrastructure to ensure spatial biology is fully interoperable across teams and platforms to save time in your clinical trials

Unlock

smarter spatial biology partnerships to maximize ROI, scale breakthroughs, and bring better treatments to patients faster

7

Explore the 2025 Full Event Guide

  • 18+ Expert Speakers delivering high-impact insights, practical experience and future-focused perspectives.
  • 14+ Case Studies showcasing fresh data and proven strategies to help you maximise the value of spatial biology across your pipeline.
  • 8+ Hours of Dedicated Networking giving you ample time to connect with peers, benchmark progress, and spark new collaborations.
  • 4+ Panel & Discussion Sessions providing open forums to tackle practical challenges, share diverse viewpoints, and define clear actions for scaling spatial biology in drug development
3rd Spatial Biology for Drug Development Summit

Attending Companies Included

11

Explore the Agenda

Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.

8

Partner With Us

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.

17 (2)

Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.